Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences

Fast-acting insulin aspart (faster aspart) is insulin aspart (IAsp) with two added excipients, L-arginine and niacinamide, to ensure formulation stability with accelerated initial absorption after subcutaneous administration compared with previously developed rapid-acting insulins. The pharmacokinet...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanne Haahr, Tim Heise
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2020
Subjects:
Online Access:https://doaj.org/article/8f6ea16d2b274e568069cac42f9f1865
Tags: Add Tag
No Tags, Be the first to tag this record!